Want to join the conversation?
Medical & pharmaceutical company $JNJ today announced the selling of its Cordis business interests to $CAH in a deal valued at approx. $2Bil. The deal is subject to customary adjustments. The Cordis business is a global leader in the development & manufacture of interventional vascular technology & generated net revenues of approx. $780MM in 2014.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.